The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/appi.ps.201300192

Objective

This study examined treatment of obsessive-compulsive disorder (OCD) in office-based practice.

Methods

Data from the 2003–2010 National Ambulatory Medical Care Survey, a nationally representative survey of visits to U.S. office-based physicians, were used to examine outpatient visits involving treatment of adults with OCD.

Results

Among the 316 visits with a diagnosis of OCD, most were to a physician seen previously by the patient (96%), usually a psychiatrist (86%), and most patients (56%) had seen the physician at least six times in the previous year. Most visits included psychotropic medications (84%), most commonly a serotonin reuptake inhibitor (SRI) (69%). Visits less commonly included psychotherapy (39%).

Conclusions

OCD was predominantly treated by psychiatrists using SRIs, despite the prevalence of OCD in primary care and SRI prescribing practices in that setting. Given the potential shift in OCD treatment patterns after health care reform, research on OCD treatment in primary care is warranted.